Cart
sales@molnova.com
Thalidomide
CAS No. 50-35-1
Thalidomide( Contergan | Kevadon | NSC 66847 | NSC 527179 )
Catalog No. M14709 CAS No. 50-35-1
Thalidomide can directly inhibit angiogenesis induced by bFGF or VEGF in vivo.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 200MG | 45 | In Stock |
|
| 500MG | 87 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameThalidomide
-
NoteResearch use only, not for human use.
-
Brief DescriptionThalidomide can directly inhibit angiogenesis induced by bFGF or VEGF in vivo.
-
DescriptionThalidomide can directly inhibit angiogenesis induced by bFGF or VEGF in vivo.
-
In Vitro——
-
In Vivo——
-
SynonymsContergan | Kevadon | NSC 66847 | NSC 527179
-
PathwayApoptosis
-
TargetTNF
-
RecptorTNF-α
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number50-35-1
-
Formula Weight258.23
-
Molecular FormulaC13H10N2O4
-
Purity>98% (HPLC)
-
SolubilityEthanol: 2 mg/mL (7.74 mM); DMSO: 52 mg/mL (201.37 mM)
-
SMILESO=C1N(C(CC2)C(NC2=O)=O)C(C3=C1C=CC=C3)=O
-
Chemical Name2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhu YX, et al. Leuk Lymphoma. 2013 Apr;54(4):683-7.
molnova catalog
related products
-
Necrostatin-1
Necrostatin-1 is a specific RIP1 inhibitor and inhibits TNF-α-induced necroptosis with EC50 of 490 nM.
-
Varlilumab
Varlilumab (CDX-1127) is a novel human IgG1 anti-CD27 monoclonal antibody with antitumor activity, useful for studying advanced solid tumors.
-
HOMOPLANTAGININ
Homoplantaginin is a flavonoid from a traditional Chinese medicine Salvia plebeiait has a protective and therapeutic effect on hepatocyte injury and shows potent inhibitory activities against influenza.
